Literature DB >> 26654740

Reconstructive vascular surgery and the extent of tissue damage due to diabetic foot ulcers relates to risk of new ulceration in patients with PAD.

T Elgzyri1, J Larsson2, P Nyberg3, J Thörne4, K-F Eriksson5, J Apelqvist1.   

Abstract

OBJECTIVE: There is limited information regarding new ulceration following the healing of ischaemic foot ulcers in diabetic patients. Our aim is to study new ulcerations in the same foot as the previous ulcer(s) in patients with diabetes and severe peripheral artery disease (PAD).
METHOD: Patients with diabetes and severe PAD who healed from previous ulcer(s) (Wagner grade 1-5, at or below the ankle), were recruited for the prospective study from the time of healing of their ulcer. Patients were followed up regarding new ulceration, and their treatments and ulcer status noted either directly or on examination of medical records.
RESULTS: We analysed the data on 602 patients with diabetes and severe PAD with healed foot ulcers, either primarily (n=443, 74%) or after minor amputation (n=159, 26%). Of these 51% (n=305) had revascularisation before healing from the previous ulcer, 34% (n=202) developed a new ulcer on the same foot within 15 months (range 0-106). Amputation was required by 22% (n=45) of patients, with a new ulcer on the same foot. The median survival time of all patients (n=602) was 54 months. By regression analysis, a low maximal Wagner grade for the previous ulcer and reconstructive vascular surgery was related to a decreased risk of developing new ulcers in the same foot.
CONCLUSION: Patients with diabetes and ischaemic foot ulcers have a high-risk for developing new ulcers and amputation in the same foot after healing. The extent of tissue involvement in the previous ulcer and reconstructive vascular surgery affected the risk for development of new ulcers.

Entities:  

Keywords:  PAD; amputation; diabetic foot; new ulceration; peripheral artery disease; re vascularisation

Mesh:

Year:  2015        PMID: 26654740     DOI: 10.12968/jowc.2015.24.12.590

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  2 in total

1.  microRNA-155 inhibition restores Fibroblast Growth Factor 7 expression in diabetic skin and decreases wound inflammation.

Authors:  João Moura; Anja Sørensen; Ermelindo C Leal; Rikke Svendsen; Lina Carvalho; Rie Juul Willemoes; Per Trolle Jørgensen; Håvard Jenssen; Jesper Wengel; Louise Torp Dalgaard; Eugénia Carvalho
Journal:  Sci Rep       Date:  2019-04-09       Impact factor: 4.379

Review 2.  Mechanistic Actions of microRNAs in Diabetic Wound Healing.

Authors:  Marija Petkovic; Anja Elaine Sørensen; Ermelindo Carreira Leal; Eugenia Carvalho; Louise Torp Dalgaard
Journal:  Cells       Date:  2020-10-02       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.